 WALTHAM, Mass., Sept. 06, 2022 GLOBE NEWSWIRE -- Xilio Therapeutics, Inc. Nasdaq: XLO, a biotechnology company developing tumor-selective immuno-oncology therapies for people living with cancer, today announced that the company will participate virtually in a fireside chat at the Morgan Stanley 20th Annual Global Healthcare Conference on Tuesday, September 13, 2022, at 2:55 p.m. ET. 